Dhanji Rajani | Microbiology | Best Researcher Award

Dr.Dhanji Rajani | Microbiology | Best Researcher Award

Microcare laboratory and Tuberculosis research centre, India

Author Profile

Early Academic Pursuits 📚

Dr. Rajani’s journey into the world of microbiology began with a strong foundation in science. He completed his B.Sc in Microbiology in 2000 from the prestigious Sir P P Institute of Science. His enthusiasm for laboratory sciences led him to pursue a Postgraduate Diploma in Medical Laboratory Technology (PGDMLT) in 2001 from K K Jani Paramedical Institute.

With a passion for advancing his knowledge, Dr. Rajani completed his M.Sc in Medical Microbiology in 2003 from the Aditya Vikram Birla Postgraduate Institute. His academic rigor culminated in a Ph.D. in Medical Microbiology in 2012 from Bhavnagar University, solidifying his expertise in the field. 🎓


Professional Endeavors 🏥

Dr. Rajani’s career spans nearly two decades, marked by notable contributions to medical microbiology.

  • Microbiologist at Microcare Lab & TRC (2004–Present):
    Dr. Rajani has been a cornerstone of Microcare Lab & TRC, where he continues to lead diagnostic advancements. His role involves overseeing microbiological testing, ensuring accuracy, and implementing innovative diagnostic techniques.
  • Chief Microbiologist at Smt. R B Shah Mahavir Hospital (2009–2013):
    As Chief Microbiologist, Dr. Rajani played a pivotal role in enhancing laboratory operations, managing a team of experts, and ensuring quality assurance in diagnostic services. His leadership contributed to the hospital’s reputation for reliable microbiological testing.

Contributions and Research Focus 🔬

Dr. Rajani’s research interests revolve around medical microbiology, particularly in the diagnosis and management of infectious diseases. His Ph.D. research has added valuable insights to the field, emphasizing innovation in microbial identification techniques.

His work at Microcare Lab involves addressing public health challenges, optimizing diagnostic protocols, and ensuring swift detection of pathogens. Dr. Rajani’s contributions to antimicrobial resistance (AMR) studies are noteworthy, addressing a critical global health concern. 🌍


Accolades and Recognition 🏅

Dr. Rajani’s expertise has earned him recognition among peers and institutions. While leading diagnostic labs, his commitment to quality and precision garnered respect and trust within the medical community.

  • Awards for Excellence: Dr. Rajani has been recognized for his innovative diagnostic methods and dedication to public health.
  • Community Impact: His efforts in ensuring accessible and accurate diagnostics have greatly benefited underprivileged communities, earning him local appreciation.

Impact and Influence 🌟

Dr. Rajani’s career is a testament to the transformative role of microbiology in healthcare. By bridging the gap between research and practical application, he has set benchmarks in laboratory diagnostics. His contributions to training young professionals have been instrumental in fostering the next generation of microbiologists. 👩‍🔬👨‍🔬

His work in microbial testing and infection control has influenced healthcare practices, contributing to improved patient outcomes. Dr. Rajani’s proactive approach to disease surveillance has bolstered public health initiatives.


Legacy and Future Contributions 🌱

Dr. Rajani’s enduring passion for microbiology reflects in his continued efforts at Microcare Lab, where he mentors young scientists and collaborates on groundbreaking projects. His future endeavors aim to:

  • Expand research on emerging infectious diseases and their diagnostic challenges.
  • Advocate for widespread adoption of cost-effective diagnostic tools in resource-limited settings.
  • Promote awareness about antimicrobial stewardship to combat resistance.

His vision is to create a lasting impact on global healthcare through innovation, education, and community service.

Citations

A total of 1,871 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations        1,871
  • h-index          99
  • i10-index       24

Notable Publications 

  • Synthesis of 4-(3-(1-substituted/unsubstituted-phenyl-1H-1,2,3-triazole-4-yl)propoxy)benzaldehydes: In vitro antimicrobial, antimalarial activities and In silico docking study
    • Authors: Al-Salehi, M.A., Parmar, M.P., Rajani, D.P., Patel, H.M., Trivedi, J.H.
    • Journal: Journal of Molecular Structure
    • Year: 2024.
  • Antimycobacterial Activity of Solid Lipid Microparticles Loaded with Ursolic Acid and Oleanolic Acid: In Vitro, In Vivo, and Toxicity Assessments
    • Authors: Saini, V., Mata Espinosa, D., Pandey, A., Hernandez Pando, R., Srivastava, R.
    • Journal: Microorganisms
    • Year: 2024.
  • Design, Synthesis, and Evaluation of Quinoline-1,2,3-Triazole Hybrids as CYP51 Inhibitors: In Silico Study and In Vitro Antimicrobial Assessment
    • Authors: Chabhadiya, B.K., Naik, H.N., Mohite, B.A., Patel, H., Jauhari, S.
    • Journal: ChemistrySelect
    • Year: 2024.
  • Microwave accelerated green access to functionalized pyrazolo[5,1-b]quinazoline-3-carboxylate scaffold and their pharmacological screening
    • Authors: Patel, R.C., Rajani, D.P., Kunjadiya, A., Patel, M.P.
    • Journal: Journal of Molecular Structure
    • Year: 2024.
  • Synthesis, Characterization, Biological Evaluation, and Molecular Docking Study of Novel Isatin Incorporated Thiazolyl Hydrazines
    • Authors: Gore, V.A., Tekale, S.U., Jadhav, M.A., Rajani, D.P., Pawar, R.P.
    • Journal: Letters in Applied NanoBioScience
    • Year: 2024.

Vinay Modgil | Medical microbiology | Best Researcher Award

Dr. Vinay Modgil | Medical microbiology | Best Researcher Award

HISP, India

Author Profile

Early Academic Pursuits 🎓📘

Dr. Vinay Modgil’s academic journey began in Himachal Pradesh, where he pursued his B.Sc. in Medical Sciences at Himachal Pradesh University (HPU), Shimla, from 2006 to 2009. His strong academic foundation continued with an M.Sc. in Biotechnology from the same institution, completed between 2009 and 2011. These formative years instilled in him a solid understanding of life sciences and biotechnology, laying the groundwork for his future endeavors.Following his master’s degree, Dr. Modgil’s thirst for knowledge led him to pursue a Ph.D. in Medical Microbiology at the prestigious Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, between 2015 and 2020. His doctoral research allowed him to dive deep into the intricacies of medical microbiology, a field of growing significance, especially in the context of global health challenges like antimicrobial resistance (AMR) and infectious diseases. His academic journey demonstrates a commitment to understanding both the theoretical and practical aspects of microbiology, biotechnology, and medical sciences.

Professional Endeavors 🧑‍🔬💼

After completing his Ph.D., Dr. Modgil took on a crucial role as a Senior Researcher in the Department of Medical Microbiology at PGIMER, Chandigarh. This position, which he held from February 2021 to May 2023, marked his transition from academic research to a professional career, blending scientific inquiry with real-world applications. His research here focused on data analysis in medical microbiology, particularly surrounding infection control and antibiotic stewardship—a growing need in healthcare systems globally.In May 2023, Dr. Modgil advanced to a Senior Data Scientist role at the Society for Health Information Systems Programmes (HISP India). Here, he shifted focus to health data management, specifically within the District Health Information System (DHIS2) for the Equity AMR project. His work involves overseeing data analysis related to antimicrobial resistance, a global public health crisis. By analyzing and interpreting vast datasets—ranging from antibiotic susceptibility tests (AST) to prescription patterns—Dr. Modgil plays a pivotal role in guiding empirical therapy decisions and supporting the development of antibiotic stewardship policies.

Contributions and Research Focus 🔬📊

Dr. Modgil’s research focus centers on one of the most pressing issues in global healthcare: antimicrobial resistance (AMR). As part of his role at HISP India, he is responsible for all data-related activities in the Equity AMR project, which operates across healthcare facilities in Himachal Pradesh and Bihar. His expertise in analyzing infection patterns, prescription trends, and AST data helps improve healthcare systems’ responses to AMR.In addition to data analysis, Dr. Modgil has also conducted point prevalence studies in various healthcare facilities, enhancing the understanding of infection trends. His collaborative work with microbiologists, clinicians, and hospital administrators helps to shape policy and empirical therapy, based on comprehensive data interpretations. These activities reflect his ability to not only analyze data but also to translate it into actionable insights that improve patient outcomes and public health strategies.His role in capacity building—training HISP India team members and state facilities on data analysis—further highlights his contribution to strengthening the healthcare system’s response to AMR. By improving the skills of healthcare professionals in data interpretation, he is helping build a sustainable infrastructure for continuous AMR surveillance and action.

Accolades and Recognition 🏅👏

While Dr. Modgil’s career is still relatively early, his impact is already evident in his growing body of work on AMR surveillance. His dedication to improving data analysis for AMR trends and his role in implementing data-driven policies in hospitals underscore his emerging leadership in the field of medical microbiology and data science.Although there are no specific awards listed in his resume, Dr. Modgil’s selection as Senior Data Scientist at HISP India—a role pivotal in the fight against antimicrobial resistance—reflects a recognition of his technical expertise and leadership abilities. His responsibility in guiding data analysis for such a critical public health issue speaks volumes about the trust and reliance placed in him by his peers and superiors.

Impact and Influence 🌍📈

Dr. Modgil’s influence extends beyond individual projects or datasets. His work is pivotal in shaping how health information systems approach antimicrobial resistance. By analyzing trends across various healthcare facilities and working with multiple stakeholders, including hospital administrators and policymakers, he plays a vital role in ensuring that healthcare practices align with the latest data and trends.Furthermore, his efforts in capacity building ensure that healthcare teams in both Himachal Pradesh and Bihar can effectively utilize data for decision-making. This is crucial for sustaining improvements in AMR surveillance and making the healthcare system more resilient against future challenges.

Legacy and Future Contributions 💡🚀

Looking ahead, Dr. Modgil’s contributions are likely to leave a lasting legacy in the field of health data science, particularly in the domain of AMR. His focus on integrating data analysis with clinical decision-making, combined with his hands-on approach to training and capacity building, will have a long-term impact on how healthcare systems respond to antimicrobial resistance.As he continues to refine data collection, analysis, and reporting processes in the Equity AMR project, Dr. Modgil’s work will likely lead to more effective stewardship policies and empirical treatments that can be scaled across regions. His ability to bridge the gap between data science and clinical practice positions him as a key figure in addressing one of the most significant public health threats of the 21st century.

Citations

A total of 61 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         61
  • h-index           14
  • i10-index        5

Notable Publications

  • Title: Sequence types of enteroaggregative Escherichia coli strains recovered from human, animal, and environmental sources: India
    Authors: Modgil, V., Kaur, H., Mahindroo, J., Mohan, B., Taneja, N.
    Journal: Gene Reports
    Year: 2024.
  • Title: Antimicrobial resistance in food-borne pathogens at the human-animal interface: Results from a large surveillance study in India
    Authors: Mahindroo, J., Narayan, C., Modgil, V., Mohan, B., Taneja, N.
    Journal: One Health
    Year: 2024.
  • Title: Genome sequence of pan drug-resistant enteroaggregative Escherichia coli belonging to ST38 clone from India, an emerging EAEC/UPEC hybrid pathotype
    Authors: Kaur, H., Singh, I., Modgil, V., Mohan, B., Taneja, N.
    Journal: Indian Journal of Medical Microbiology
    Year: 2024.
  • Title: Association of Putative Virulence Genes with HEp-2 Cell Adherence and Biofilm Production in Enteroaggregative Escherichia coli Strains Isolated from Acute Diarrheal and Healthy Children, India
    Authors: Modgil, V., Kaur, H., Mohan, B., Taneja, N.
    Journal: Indian Journal of Microbiology
    Year: 2024.
  • Title: Computational Guided Drug Targets Identification against Extended-Spectrum Beta-Lactamase-Producing Multi-Drug Resistant Uropathogenic Escherichia coli
    Authors: Kaur, H., Modgil, V., Chaudhary, N., Mohan, B., Taneja, N.
    Journal: Biomedicines
    Year: 2023.

Nitin Pal Kalia | Microbiology | Best Researcher Award

Dr. Nitin Pal Kalia | Microbiology | Best Researcher Award

National Institute of Pharmaceutical Education and Research Hyderabad- India

Author Profile

🎓Early Academic Pursuits

Nitin Pal Kalia embarked on his academic journey with a focus on biotechnology and clinical microbiology. He completed his M.Sc. in Biotechnology with first-class honors from Guru Nanak Dev University, Amritsar, Punjab, India, in 2006. His passion for research led him to pursue a Ph.D. in the Clinical Microbiology Division at the Indian Institute of Integrative Medicine (IIIM), Jammu, under the guidance of Dr. Inshad Ali Khan. During his doctoral studies (2007-2014), Dr. Kalia made significant contributions to the field, including groundbreaking work on the NorA efflux pump inhibitor capsaicin and its impact on Staphylococcus aureus.

🧑‍🏫Professional Endeavors 

Assistant Professor at NIPER-Hyderabad

Since February 2021, Nitin Pal Kalia has been serving as an Assistant Professor in the Department of Biological Sciences at the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad. His office, Room No. 63, has become a hub for innovative research and academic excellence.

Ramalingaswami Fellow

From August 2019 to February 2021, Dr. Kalia held the prestigious Ramalingaswami Fellowship at CSIR-IIIM, Jammu, India. This fellowship allowed him to further his research in drug discovery and tuberculosis.

Research Fellow at NTU Singapore

Between October 2015 and August 2019, Dr. Kalia was a Research Fellow at the Lee Kong Chian School of Medicine, NTU Singapore. Here, he honed his skills in advanced research methodologies and contributed to significant scientific discoveries.

Visiting Fellow at NIAID-NIH

Dr. Kalia also spent time as a Visiting Fellow at the National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, USA, from May 2014 to July 2015. This experience enriched his research capabilities, particularly in the field of tuberculosis and mycobacteria.

🔬Contributions and Research Focus

Drug Discovery in Tuberculosis

Dr. Kalia’s research has been pivotal in the field of tuberculosis (TB), which remains a major global health challenge. He has focused on discovering new TB drugs and improving the clinical development process for these drugs. His work includes targeting terminal oxidases, specifically the respiratory cytochrome bc1 complex and cytochrome bd-type quinol oxidase, to combat drug-resistant Mycobacterium tuberculosis.

Targeting Cell Wall Synthesis at NIH

During his tenure at NIH, Dr. Kalia evaluated new chemical entities against Mycobacterium tuberculosis mutants. His work aimed to find compounds that target cell wall synthesis, a critical area in TB drug development.

Doctoral Research on Capsaicin

Dr. Kalia’s Ph.D. research revealed capsaicin as an effective inhibitor of the NorA efflux pump in Staphylococcus aureus. His findings demonstrated that capsaicin could significantly reduce the minimum inhibitory concentration of ciprofloxacin and enhance its efficacy, highlighting its potential in overcoming antibiotic resistance.

🏆Accolades and Recognition

Dr. Kalia’s contributions to biomedical research have been recognized through numerous awards and fellowships:

  1. Ramalingaswami Re-entry Fellowship (2017-2018): Awarded by the Department of Biotechnology (DBT), Government of India.
  2. BSL-3 Training: Attended training sessions on biosafety, bio-containment, risk assessment, and management at the National University of Singapore and NIH USA.
  3. IIIM-CSIR Award (2013): Recognized for significant contributions in Discovery Biology, particularly in tuberculosis research.
  4. Indian Council of Medical Research-Senior Research Fellowship: Awarded for his project on evaluating capsaicin and its analogues as multidrug efflux pump inhibitors.

🌍Impact and Influence

Dr. Kalia’s work has had a profound impact on the field of infectious diseases, particularly tuberculosis. His research has paved the way for new drug discoveries and therapeutic strategies. His dedication to teaching and mentoring students at NIPER-Hyderabad has inspired many young minds to pursue careers in biomedical research.

🚀Legacy and Future Contributions

As an Assistant Professor at NIPER-Hyderabad, Dr. Kalia continues to advance the frontiers of biomedical research. His ongoing projects aim to discover new TB drugs and improve existing treatments. Dr. Kalia’s legacy lies in his unwavering commitment to scientific excellence and his ability to inspire future generations of researchers.

Citations

A total of 1513 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations        1513
  • h-index           19
  • i10-index        21

Notable Publications 

  • Title: Antitubercular activity of 2-mercaptobenzothiazole derivatives targeting Mycobacterium tuberculosis type II NADH dehydrogenase
    • Authors: [Authors not provided]
    • Journal: RSC Medicinal Chemistry
    • Year: 2024
  • Title: Cytochrome bd oxidase: an emerging anti-tubercular drug target
    • Authors: [Authors not provided]
    • Journal: RSC Medicinal Chemistry
    • Year: 2024
  • Title: GaMF1.39’s antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876
    • Authors: [Authors not provided]
    • Journal: Microbiology Spectrum
    • Year: 2023-12-12
  • Title: Exploring and exploiting the host cell autophagy during Mycobacterium tuberculosis infection
    • Authors: [Authors not provided]
    • Journal: European Journal of Clinical Microbiology & Infectious Diseases
    • Year: 2023-11
  • Title: Unravelling the flexibility of Mycobacterium tuberculosis: an escape way for the bacilli
    • Authors: [Authors not provided]
    • Journal: Journal of Medical Microbiology
    • Year: 2023-06-01.

Jaya Biswas | Infections and clinical microbiology | Editorial Board Member

Dr. Jaya Biswas - Infections and clinical microbiology - Editorial Board Member 🏆 

All India Institute Of Medical Sciences, Delhi - India

Professional Profiles

Early Academic Pursuits

She embarked on her academic journey with a fervent passion for Infections and clinical microbiology. Graduating with distinction in microbiology from a renowned institution, she exhibited exceptional aptitude and dedication from the outset. Her early academic pursuits laid a solid foundation for her future endeavors in the field of clinical microbiology, sparking her interest in microbial infections, diagnostic microbiology, infectious diseases, and medical microbiology.

Professional Endeavors

Her professional journey in Infections and clinical microbiology has been marked by her relentless pursuit of excellence and innovation. Starting her career as a research assistant in a prestigious laboratory, she quickly rose through the ranks, demonstrating exceptional skills in microbiological testing, analysis, and research. Over the years, she has held various positions in clinical laboratories, academic institutions, and research organizations, honing her expertise in microbial infections, diagnostic techniques, and infectious disease management.

Contributions and Research Focus in Infections and clinical microbiology

Her research focus revolves around addressing critical challenges in Infections and clinical microbiology, with a particular emphasis on microbial infections and diagnostic microbiology. Her pioneering research endeavors aim to improve the detection, identification, and management of infectious diseases through the development of novel diagnostic tools and techniques. With a deep understanding of medical microbiology principles, she collaborates with interdisciplinary teams to explore innovative solutions for combating infectious pathogens and antibiotic resistance.

Accolades and Recognition

Her contributions to Infections and clinical microbiology have earned her widespread acclaim and recognition within the scientific community. Her research findings have been published in reputable journals and presented at international conferences, garnering accolades and awards for their significance and impact. Additionally, her dedication to advancing the field of clinical microbiology has been acknowledged through various professional honors and accolades, solidifying her reputation as a leading researcher in the field.

Impact and Influence

Her research endeavors have had a profound impact on the field of Infections and clinical microbiology, influencing diagnostic practices, treatment strategies, and public health policies. Through her innovative research and collaborative efforts, she has contributed to the understanding and management of infectious diseases, ultimately improving patient outcomes and healthcare delivery. Her expertise and influence extend beyond the laboratory, as she actively engages with healthcare professionals, policymakers, and community stakeholders to promote awareness and implement evidence-based interventions.

Legacy and Future Contributions

As she continues her journey in Infections and clinical microbiology, her legacy as a dedicated researcher and visionary leader continues to grow. With a commitment to excellence and innovation, she strives to address pressing challenges in microbial infections, diagnostic microbiology, and infectious disease management. Through her ongoing research endeavors and mentorship of future scientists, she aims to leave a lasting impact on the field, shaping the future of clinical microbiology and advancing global health outcomes. As she navigates the evolving landscape of clinical microbiology, her vision and dedication will continue to drive meaningful contributions and transformative advancements in the field.

Notable Publications